C3 Glomerulopathy Diagnosis, Current Treatments, and Emerging Therapies

Area of Science:

• Nephrology
• Immunology
• Complement System Biology

Background:

• C3 glomerulopathy (C3G) is a kidney disease marked by C3 complement protein deposition in glomeruli, leading to inflammation.
• It stems from alternative complement pathway dysregulation, affecting both children and adults due to genetic or acquired factors.
• C3G diagnosis relies on kidney biopsy, with approximately 50% of patients progressing to kidney failure.

Purpose of the Study:

• To provide a comprehensive overview of C3 glomerulopathy.
• To detail its pathophysiology, clinical presentations, and diagnostic criteria.
• To discuss current treatment guidelines and emerging clinical trials.

Main Methods:

• This is a review article, synthesizing existing knowledge.
• Information was gathered from relevant scientific literature.
• Key aspects covered include pathophysiology, clinical features, diagnostics, and therapeutics.

Main Results:

• C3G is characterized by specific glomerular C3 deposition patterns.
• Dysregulation of the alternative complement pathway is a key pathogenic mechanism.
• Current treatments show variable efficacy, underscoring the need for novel approaches.

Conclusions:

• C3G is a complex glomerular disease with significant progression to kidney failure.
• Accurate diagnosis via kidney biopsy is crucial.
• Further research and clinical trials are essential for improved C3G management.